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Anti-cancer and bioavailability
of arachidin-1 and arachidin-3 in
colon cancer cells
Macy R. Shirley*, Cindi Brownmiller†, Wing Shun Lam§, and Sun-Ok Lee‡
Abstract
Cancer is a common cause of death in the United States and locally in the state of Arkansas. Modifiable factors such as tobacco use, physical activity, and diet lead to reduced incidence of colon
cancer diagnosis. Plant-based foods may contain phytochemicals that confer health promoting
properties. Specifically, peanuts contain phytochemicals known as resveratrol, arachidin-1, and
arachidin-3 that have been linked to anticancer activities. However, few research studies have
been done on arachidin-1 and arachidin-3 that could develop understanding of their health promoting properties or nutraceutical applications. The objectives of this study were to (1) determine
the most effective concentration of arachidin-1 and arachidin-3 for inhibiting cell proliferation
and (2) assess the bioavailability of these compounds. Concentrations of 0, 5, 10, and 20 µM
arachidin-1 and arachidin-3 were applied and cell viability was measured at 0, 24, and 48 hours.
Significant reduction of cell proliferation occurred with treatments of 10 and 20 µM arachidin-1
and 10 and 20 µM arachidin-3 in comparison with the control. Due to the limitations of high performance liquid chromatography (HPLC) detection, no transport values were determined when
arachidin-1 and arachidin-3 were applied in 50 and 100 µM concentrations. The findings suggest
that arachidin-1 and arachidin-3 inhibit cell proliferation in human colon cancer cells. Further
research is needed to understand the bioavailability of arachidin-1 and arachidin-3.

* Macy Shirley is a 2017 honors program graduate with a major in Human Nutrition and Hospitality Innovation .
† Cindi Brownmiller is a Laboratory Specialist in the Department of Food Science.
§ Wing Shun Lam is a Graduate student in the Department of Food Science.
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Introduction
Cancer is one of the leading causes of mortality in Arkansas and throughout the United States. Specifically, an incidence rate of 50.1 per 100,000 for males and 37 per 100,000
for females exists for colon cancer in Arkansas (Siegel et
al., 2017). The mortality rate for colon cancer in Arkansas
is approximately 18.2 per 100,000 people, which ranks third
highest compared with other states in the United States
(National Cancer Institute, 2015).
Genetic and lifestyle factors are potentially influential
in the development of colon cancer (Burt et al., 2010). Prevention reduces incidence and mortality rates associated
with colon cancer (Siegel et al., 2016). Amin et al. (2009)
reported an inverse relationship between a diet rich in fruits
and vegetables and diagnosis with colon cancer. This relationship can be attributed to the phytochemicals found in
fruits and vegetables (Amin et al., 2009). The peanut plant
(Arachis hypogaea L.) is a source of phytochemicals known
as stilbenoids, which confer cancer preventative properties
following extraction from the root or kernel of the peanut
plant. Arachidin-1, arachidin-3, and resveratrol are stilbenoids derived from the peanut plant (Huang et al., 2010).
While a significant amount of research has been conducted involving resveratrol, there is limited information available about the health-promoting properties of arachidin-1
and arachidin-3 (Chang et al., 2006).
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Understanding the bioavailability of phytochemicals is
essential for determining their biological and health effects
in humans. Therefore, the objectives of the present study
were to: 1) determine the effective concentrations of arachidin-1 and arachidin-3 for inhibiting colon cancer cell
growth, and 2) assess the intestinal transport of arachidin-1 and arachidin-3 to determine which compound is
more bioavailable.

Materials and Methods
Arachidin-1 and arachidin-3 were generously donated
by Dr. Medina-Bolivar in their pure form (Arkansas State
University, Jonesboro, Ark.). All reagents and media components were purchased from ThermoFisher (Waltham,
Mass.).
High Performance Liquid Chromatography Analysis
To measure arachidin-1 and arachidin-3, a System Gold
high performance liquid chromatograph (HPLC; Beckman-Coulter, Fullerton, Calif.) with autosampler (model
508), dual pump (model 126), photodiode array detector
(model 168) with Beckman-Coulter System 32 Karat software (version 8, 2006) was used. Arachidin-1 and arachidin-3 were separated using the method proposed by Abbott et al. (2010) to ensure use of pure compounds. Separation of the phytochemicals occurred with the Phenomenex

DISCOVERY • Vol. 18, Fall 2017

(Torrance, Calif.) Aqua 5 µM C18 (250 × 4.6 mm) column
containing a binary gradient of 2% formic acid [mobile
phase A] and 99:1 (v/v) acetonitrile/mobile phase A [mobile phase B]. The gradient began with 10% B and increased uniformly to 18% for 8 minutes. The gradient was
then held at 18% B for 2 minutes before increasing linearly
to 25% B over the course of 5 minutes, and increasing to
35% B for 3 minutes. Then the gradient remained constant
and uniform in the mobile phase for 20 minutes at 35%.
Mobile phase B increased uniformly to 60% over the course
of 59 minutes before returning to the initial binary gradient of 10%. The peaks of arachidin-1 and arachidin-3 were
monitored at 340 nm (Bettis, 2016).
Cell Culture
Caco-2 cells, a human epithelial colorectal adenocarcinoma cell line, purchased from American Type Culture
collection (ATCC, Rockville, Md.) were incubated at 37 °C
in an atmosphere containing 5% CO2. Cells were cultivated in Dulbecco’s Modified Eagle’s Medium (DMEM) with
10% fetal bovine serum (FBS), 1% nonessential amino acids solution, and 1% antibiotic-antimycotic (Bettis, 2016;
Thurow, 2012). Cell cultures were maintained under sterile
conditions and incubated at 37 °C, 70% humidity, and 5%
CO2 in the incubator (VWR® symphony™, VWR® International LLC, Radnor, Pa.).
Cell Viability Assay
Caco-2 cells, passage number 36-42, were used for the
viability assay. For a standard curve, cells attached to the
chambers of a 96-well microplate (Corning Inc., Tewksbury, Mass.) for 24 hours after being seeded in a range from
0 to 3.2 × 103 cells with 100 µL working media (WMEM).
For the experiment, cells (2 × 103) were seeded in wells of
a 96 well plate for 24 hours. Three separate plates were prepared for each of the five experiments performed during
this study. At the end of the 24 hour period, media was aspirated and cells were treated with 100 µL of 0, 5, 10, or
20 µM concentration of arachidin-1 or arachidin-3. These
concentrations were chosen based on results from previous studies evaluating cell viability. Dried arachidin-1
or arachidin-3 was suspended in DMEM in the quantity deemed calculated when the density was converted
to moles. The compounds were suspended in media to
make a 100 µM stock solution and dilutions with media
occurred accordingly. Each treatment was applied in quadruplicate. The control was treated with 100 µL of 0.1%
DMSO. Measurements were obtained at 0 (T0), 24 (T24),
and 48 (T48) hours following treatment to determine cell
viability. When the absorbance was read at T0, T24, and
T48, 20 µL of cell titer reagent (CellTiter96® Aqueous One

Solution Proliferation Assay, Promega Co., Madison, Wis.)
was added to each well. Using a plate reader (Synergy HT
Multi-Mode Microplate Reader, BioTek Instruments, Inc.
Winooski, Vt.) the absorbance of the cells was measured at
490 nm. This absorbance was converted to the number of
viable cells using an equation from the standard curve. Based
on the number of viable cells present at T0, a proliferation
percentage was calculated for T24 and T48 (Bettis, 2016).
Intestinal Transport Assay
Caco-2 cells were seeded at a density of 1 × 105/cm2 cells
on polycarbonate membrane inserts (12 mm diameter, pore
size 0.4 µm) fitted in bicameral chambers (Corning Inc.,
Tewksbury,Mass.).Cellmonolayerintegritywasconfirmed by
determining the transepithelial electrical resistance (TEER)
values using the Millicell ERS-2 Voltohmmeter (EMD Millipore, Billerica, Mass.). After seeding, media was aspirated from both the apical and basal chambers. One mL of
phosphate-buffered saline (PBS) was added to the basal
chamber and 0.5 mL of 50 and 100 µM arachidin-1 or arachidin-3 was added to the apical chamber.
For time 0 h, transport media containing arachidin-1
(or arachidin-3) was loaded and 0.5 mL of PBS were collected immediately in a vial. Each vial was preserved with
25 µL trifluoroacetic acid (TFA) and 25 µL 70% ethanol. At
this point, 0.5 mL of PBS was replaced in the basal chamber. The plate was incubated at 37 °C for 30 minutes. For
time 0.5 h and time 1 h, steps performed for time 0 were
repeated. The plate was incubated for 1 hour following
time 1. At the end of 2 hours, media from the apical was
collected in a vial and rinsed with 0.5 mL of PBS three
times. Phosphate-buffered saline was removed from the
basal chamber, collected in a vial, and rinsed with 1 mL
of PBS. Each vial was preserved with 25 µL TFA and 25 µL
70% ethanol. All aliquots were frozen at -20 °C until analysis via HPLC. Apparent permeability coefficients (Papp)
were calculated using the following equation:

Where dQ/dt is the rate of permeation across the cell, A
is the area of the cell monolayer, and C0 is the initial concentration of the apical chamber.
Statistical Analysis
All statistical analyses were carried out by JMP software
v. 13 (SAS Institute, Inc., Cary, N.C.) using a one-way analysis of variance test (ANOVA). The ANOVA results were
compared with the student’s t test. Data were represented
as means ± standard error of mean (SEM). Statistical significance was accepted at P < 0.05.
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Results and Discussion
Identification of Arachidin-1 and Arachidin-3
Arachidin-1 and arachidin-3 used for this experiment
were identified as pure compounds at 304 nm (Fig. 1).
Cell Viability after Arachidin-1 and Arachidin-3 Treatment
Arachidin-1 and arachidin-3 treatments (10 µM and 20
µM) reduced cell viability compared to control (Figs. 2 and
3). At the 48 hour time point, 10 and 20 µM concentrations of arachidin-1 resulted in a significant reduction of
cell viability (%) compared to the control (P < 0.05) (Fig.
2). There was no significant difference of cell viability be-

tween treatments and control at time point 24 hours. The
cell viability was significantly reduced in treatments of 10
and 20 µM arachidin-3 compared to 5 µM arachidin-3
and the control at time point 48 hours (P < 0.05; Fig. 3).
At time point 48 hours, 10 and 20 µM concentrations of
arachidin-1 showed the lowest cell viability in comparison
with cell viability measured after treatments of 10 or 20
µM arachidin-3 or control (P < 0.05; Fig. 4).
Intestinal Transport Assay of Arachidin-1 and
Arachidin-3 Treatment
Arachidin-1 was not detected in samples from both apical
and basal chambers treated with 50 µM or 100 µM at time
point 2 hours (Fig. 5). At time point 2 hours, a trace amount
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Fig. 1. High Performance Liquid Chromatogram of arachidin-1 and arachidin-3 at 340 nm.

Fig. 2. Effect of arachidin-1 on the survival of Caco-2 cells. Values with different letters at the
same incubation time are significantly different (P < 0.05).
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of arachidin-3 was detected in apical sample treated with
100 µM (Fig. 6). Apparent permeability coefficient (Papp)
values of arachidin-1 and archidin-3 were not determined.
The peanut root contains phytochemicals that confer
anticancer and anti-inflammatory effects to the body for a
nutraceutical approach. Arachidin-1 and arachidin-3 have
been involved in limited research regarding their health
effects for cancer prevention. Therefore, the anti-colon
cancer activity and bioavailability of arachidin-1 and archidin-3 have been investigated in this study.
In order to understand the anticancer properties linked
with arachidin-1 and arachidin-3, it is important to evaluate

the effect of these compounds on colon cancer cell proliferation. In the present study, both arachidin-1 and arachidin-3 treatments (10 and 20 µM) resulted in reduced cell
proliferation rates compared with the control (P < 0.05). The
most significant reduction of cell proliferation occurred at
time point 48 hours when arachidin-1 was applied at concentrations of 10 and 20 µM in comparison with the control or 5, 10, and 20 µM arachidin-3 treatments (P < 0.05).
A few studies have investigated the anticancer properties of arachidin-1 and arachidin-3 in different cell lines
with different concentrations of stilbenoids (Ball et al., 2015;
Huang et al., 2010; Ko et al., 2013). Cell viability results

Fig. 3. Effect of arachidin-3 on the survival of Caco-2 cells. Values with different letters at the same incubation
time are significantly different (P < 0.05).

Treatments
Fig. 4. Summarized effects of arachidin-1 and arachidin-3 on the survival of Caco-2 cells. Values with different
letters at the same incubation time are significantly different (P < 0.05).
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from a study on the effect of 0 to 20 µM concentrations
of arachidin-1, arachidin-3, and resveratrol on human
leukemia cell (HL-60) proliferation reported that arachidin-1 resulted in reduced cell viability (Huang et al., 2010).
Another study investigated the effects of metformin and
arachidin-1 upon dose-dependent application to A549
and H1975 human lung cancer cell lines. Metformin is an
anti-diabetic drug associated with anticancer properties.
Treatments of 0.5, 1, 5, and 10 µM arachidin-1 with 25 µM

metformin over the course of a 4-day incubation period
resulted in reduced cell viability. (Ko et al., 2013).
The 10 and 20 µM concentrations of arachidin-1,
resveratrol, piceatannol, and arachidin-3 were applied
to rotavirus infected HT29.F8 cells from the human adenocarcinoma line of the intestine. These concentrations
of stilbenoids did not decrease cell viability substantially.
However, application of arachidin-1 or arachidin-3 resulted
in reduced viral replication and can be attributed to an-
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Fig. 5. High performance liquid chromatogram of (A) arachidin-1 standard, (B) apical sample treated with 100
µM of arachidin-1 and (C) basal sample treated with 100 µM of arachidin-1 at time point 2 hours.
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tioxidant activity of these compounds (Ball et al., 2015).
Additional research must be conducted to understand the
effects of stilbenoids from the peanut plant on cell viability.
Previous studies regarding the transport abilities of arachidin-1 and arachidin-3 have not been conducted. Due
to the limitations of detection in the HPLC system, the apparent transport of arachidin-1 and arachidin-3 were not
calculated. Additional research must be conducted with
higher concentrations of arachidin-1 and arachidin-3 to
evaluate bioavailability.

0.10

Conclusions
The results of this study indicate that concentrations
greater than 10 µM arachidin-1 and arachidin-3 reduced
cell viability in colon cancer cells in comparison with the
control. Arachidin-1 was more effective for inhibiting
cell proliferation than arachidin-3. No apparent intestinal transport occurred, so it is likely that concentrations
of arachidin-1 and arachidin-3 greater than 100 µM are
needed to determine bioavailability. Additional research is
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Fig. 6. High performance liquid chromatogram of (A) arachidin-3 standard, (B) apical sample treated with 100
µM of arachidin-3 and (C) basal sample treated with 100 µM of arachidin-3 at time point 2 hours.
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needed to establish the chemopreventative or nutraceutical applications of arachidin-1 and arachidin-3.
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